Recent years have witnessed dramatic improvements in nanotechnology-based cancer
therapeutics, and it continues to evolve from the use of conventional therapies …

Although cancer treatment has improved dramatically over recent decades, it continues to
remain among the most challenging public health issues. Comprehensive cancer …

Cancer continues to pose a severe threat to global health, making pursuing effective
treatments more critical than ever. Traditional therapies, although pivotal in managing …

Nanodrugs represent novel solutions to reshuffle repurposed drugs for cancer therapy. They
might offer different therapeutic options by combining targeted drug delivery and imaging in …

The majority of nanomedicines in (pre) clinical trials are based on established drugs, such
as doxorubicin and paclitaxel. Does that make sense? To some extent yes, because a lot of …

Nanotechnology has made a significant impact on basic and clinical cancer research over
the past two decades. Owing to multidisciplinary advances, cancer nanotechnology aims to …

Conventional cancer therapies are restrained by morbid off-target effects and the frequent
emergence of chemotherapy drug resistance. These limitations have motivated advances in …

Chemotherapy remains one of the most prevailing regimens hitherto in the fight against
cancer, but its development has been being suffering from various fatal side effects …

Nanotechnology-based chemotherapeutics and imaging agents represent a new era of
“cancer nanomedicine” working to deliver versatile payloads with favorable …

Nanotechnology has been continuously challenging the way we perceive diagnostics and
therapy, and therefore impacting the way we diagnose, image, and treat cancer [1]. Novel …